We are live on ! Find out more
BCAR

BANK OF THE CAROLINAS CORP COM STK
BCAR

Delisted

BCAR was delisted on the 5th of March, 2012.

1 hedge funds and large institutions have $2.62M invested in BANK OF THE CAROLINAS CORP COM STK in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 11 (0)

3% less capital invested

Capital invested by funds: $2.7M → $2.62M (-$85K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
Holders Change %
0%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
MCM
Maltese Capital Management
New York
-$145K
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
1
Maltese Capital Management
New York
$2.62M -$145K -1,050,449 -5%

BCAR Hedge Fund Activity: Q2 2015 in Review

1 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in BANK OF THE CAROLINAS CORP COM STK (BCAR) for Q2 2015, worth a combined $2.62M — down 3.1% from $2.7M a quarter earlier.

Fund positioning in BCAR was balanced in Q2 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Maltese Capital Management, cutting an estimated $145K.

  • 1 institutional investor held BANK OF THE CAROLINAS CORP COM STK (BCAR) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $2.62M of BANK OF THE CAROLINAS CORP COM STK stock for Q2 2015, down 3.1% quarter-over-quarter.
  • 0 funds opened new BANK OF THE CAROLINAS CORP COM STK positions in Q2 2015 and 0 closed out.
  • The largest BANK OF THE CAROLINAS CORP COM STK seller in Q2 2015 was Maltese Capital Management, an estimated $145K sold.

Based on aggregated 13F filings for Q2 2015.